We are excited to announce that Osgenic has successfully raised $1,500,000 in our latest funding round鈥攁 transformative milestone in our mission to decrease preventable surgical complications. As a physician-led technology company, Osgenic brings together the best of medical science and cutting-edge technologies to create solutions that are fit for purpose. Our company prides itself on being co-owned by over 500 medical doctors, which means that every decision we make is grounded in real-world clinical experience and driven by a deep sense of responsibility towards the medical community. This robust network of professionals has been instrumental in guiding our product development, ensuring that the solutions we create are not only innovative but also seamlessly integrate into everyday clinical realities.
This new funding injection will primarily be allocated to scaling our research and development efforts, accelerating the creation of new technologies designed to enhance surgical safety. By investing in state-of-the-art development and refining existing protocols, we aim to further empower healthcare professionals with tools that contribute to safer surgeries and better patient outcomes. Additionally, part of these funds will be dedicated to expanding our collaborative initiatives with top-tier hospitals and surgical centers, ensuring that our innovations align perfectly with the continual evolution of clinical practices. With this significant capital boost, Osgenic is poised to intensify our efforts in reducing surgical complications and setting new standards in medical technology. We are deeply grateful for the support from our investors and the trust of the medical community, and we look forward to driving forward safer, smarter surgery solutions.
